Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESSENCE: Voclosporin in Plaque Psoriasis
NCT00408187Phase 3Completed
- Sponsor
- Aurinia
- Start
- Dec 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial of voclosporin in plaque psoriasis (3 arms), sponsored by Aurinia. Primary endpoint: Static Physician's Global Assessment Response at 12 weeks. Started Dec 2006; status: completed.
02
Drugs
voclosporin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00408187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408187.